Katharina Schindowski
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms 6
- Biological Psychiatry top 2%
- Tryptophan and brain disorders 6
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 13
- Developmental Neuroscience top 2%
- Physiology top 2%
- Alzheimer's disease research and treatments 19
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Protein purification and stability 7
- Glycosylation and Glycoproteins Research 6
-
- Cholinesterase and Neurodegenerative Diseases 6
- Co-authors
- Luc BuéeKarim BélarbiAnne EckertWernér E.G. MüllerAlexis BrettevilleMalika HamdaneSilke LeutnerKarelle Leroy
- Journals
- Journal of Cell Science (1 paper)American Journal Of Pathology (2 papers)International Journal of Pharmaceutics (1 paper)
- Partner nations
- GermanyFranceSwitzerland
In The Last Decade
Katharina Schindowski
51 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 114
- Neurology 532
- Biological Psychiatry 160
- Pharmaceutical Science 373
- Developmental Neuroscience 182
- Physiology 1.0k
Countries citing papers authored by Katharina Schindowski
This map shows the geographic impact of Katharina Schindowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Schindowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Schindowski more than expected).
Fields of papers citing papers by Katharina Schindowski
This network shows the impact of papers produced by Katharina Schindowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Schindowski. The network helps show where Katharina Schindowski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katharina Schindowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 38 | |
| 4 | 2023 | 12 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 17 | |
| 7 | 2021 | 25 | |
| 8 | 2018 | 5 | |
| 9 | 2014 | 2 | |
| 10 | 2013 | 13 | |
| 11 | 2011 | 29 | |
| 12 | 2010 | 59 | |
| 13 | 2008 | 270 | |
| 14 | 2006 | 298 | |
| 15 | 2006 | 35 | |
| 16 | 2004 | 45 | |
| 17 | 2001 | 77 | |
| 18 | 2000 | 50 | |
| 19 | 2000 | 61 | |
| 20 | 1999 | 9 |
About Katharina Schindowski
Katharina Schindowski is a scholar working on Biological Psychiatry, Pharmaceutical Science and Neurology, having authored 54 papers that have together received 2.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (19 papers), Advanced Drug Delivery Systems (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Protein purification and stability (7 papers), Glycosylation and Glycoproteins Research (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Tryptophan and brain disorders (6 papers). The work is most often cited by research in Neurology (532 citations), Biological Psychiatry (160 citations) and Pharmaceutical Science (373 citations). Katharina Schindowski has collaborated with scholars based in Germany, France and Switzerland. Frequent co-authors include Luc Buée, Karim Bélarbi, Anne Eckert, Wernér E.G. Müller, Alexis Bretteville, Malika Hamdane, Silke Leutner, Karelle Leroy, Jean‐Pierre Brion and Séverine Bégard. Their work appears in journals such as Journal of Cell Science, American Journal Of Pathology and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.